CANADA LIFE ASSURANCE Co
InsurancePosition in BEAM — Beam Therapeutics Inc.
CIK 1046192
WINNIPEG, A2
Position in BEAM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,032,379
+$446,376 QoQ
Shares Held
30,081
+22.3% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 274 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. BEAM ranks #30 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in BEAM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,032,379 | 30,081 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $586,003 | 24,591 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $575,772 | 20,771 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $722,323 | 29,762 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $479,001 | 28,160 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $173,719 | 8,895 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $211,618 | 8,533 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $224,763 | 9,174 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $206,886 | 8,830 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $258,538 | 7,825 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $202,217 | 7,429 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $153,679 | 6,390 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $108,242 | 3,390 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $97,647 | 3,189 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $134,303 | 3,434 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $141,347 | 2,967 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $111,988 | 2,893 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $104,744 | 1,828 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $140,413 | 1,762 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $147,829 | 1,699 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $218,678 | 1,699 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $83,321 | 1,041 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $114,785 | 1,406 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $34,615 | 1,406 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $39,368 | 1,406 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||